Krsnaa Diagnostics logo

Krsnaa Diagnostics

KRSNAA NSE
₹496.45 1.20 (0.24%)
Market Cap
₹1,610 Cr
P/E
16.28

Krsnaa Diagnostics (KRSNAA) share price was ₹496.45 at the 28 Oct 2026 close; market capitalisation ₹1,610 Cr; P/E (TTM) 16.28; sector Healthcare Services. The share price fell 37.6% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 20.0% year on year to ₹210.7 Cr and net profit fell 19.5% year on year to ₹16.5 Cr (compared with Jun 2025). Promoters held 27.11% of Krsnaa Diagnostics in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 48/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹496.45 −299.20 −37.60% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹1,610 Cr
P/E (TTM)
16.28
EBITDA
₹255 Cr
Return on Equity
10.35%
Debt to Equity
0.54
Book Value
₹302.23
EPS (TTM)
₹30.49
52W High
₹838.00
52W Low
₹486.00

Price-based figures as of 28 Oct 2026, 15:31 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Dr Lal Pathlabs
₹1,922.3059.4432,266 Cr12.860.26%20.06%25.67%2,996 Cr545 Cr
Vijaya Diagnostic Centre
₹1,442.8079.1414,861 Cr15.530.14%18.07%19.22%879 Cr187 Cr
Metropolis Healthcare
₹551.2056.6511,431 Cr7.610.91%12.54%15.73%1,733 Cr203 Cr
Thyrocare Technologies
₹494.5044.637,871 Cr15.352.84%27.79%33.84%894 Cr176 Cr
Nephrocare Health Services
₹628.40149.986,319 Cr5.660.00%6.88%13.46%1,079 Cr85 Cr
Suraksha Diagnostic
₹311.7045.311,623 Cr6.630.16%12.90%14.70%329 Cr35 Cr
Krsnaa Diagnostics (this company)
₹496.4516.281,610 Cr1.640.40%10.35%10.64%862 Cr98 Cr
Median 7 companies₹551.2056.657,871 Cr7.610.26%12.90%15.73%894 Cr176 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
48 Average
Overall score
Data confidence 98/100

Category scores

Quality Good 65
Returns, margins, earnings quality 22%
Valuation Strong 73
Cheap vs sector & own history 24%
Growth Poor 21
Sales & profit trajectory 9%
Financial Health Poor 29
Solvency, leverage, coverage 9%
Momentum Poor 20
Trend strength, vol-adjusted 12%
Ownership Poor 33
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Weaknesses

5
  • The company has delivered a poor sales growth of 11.8% over past five years.
  • Promoter holding is low: 27.1%
  • Company has a low return on equity of 9.26% over last 3 years.
  • Company has high debtors of 163 days.
  • Working capital days have increased from 25.4 days to 65.9 days

Technical Indicators

Oscillators

BearishNeutralBullish

Bullish

Bearish
2
Neutral
3
Bullish
4

Overall

BearishNeutralBullish

Bearish

Bearish
12
Neutral
3
Bullish
4

Moving Averages

BearishNeutralBullish

Bearish

Bearish
10
Neutral
0
Bullish
0
Analyst Rating
Based on 2 analysts
BUY SHARE100%

2 of 2 analysts rate Buy, 0 Hold, 0 Sell.

Updated 28 Oct 2026

BUY
2
100%
HOLD
0
0%
SELL
0
0%

Growth Rate

Revenue Growth
9.9% lower than 3Y

change over 1 year

Net Income Growth
30.67% higher than 3Y

change over 1 year

Cash Flow Change
63.86%

change over 1 year

EBITDA Margin Change
7.71%

change over 1 year Operating margin 27% · Jun 2026

Analyst Forecasts

Forecast For
Sep 26 consensus · EBITDA
₹65.4 Cr +0.3% vs Jun 26
Reported High Mean Low

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
132
147
152
159
163
179
165
175
176
183
159
173
211
Expenses
100
116
113
116
120
126
117
121
126
125
112
116
154
Operating Profit
32
31
38
43
43
52
48
53
50
58
48
57
57
OPM %
24%
21%
25%
27%
26%
29%
29%
31%
29%
32%
30%
33%
27%
Other Income
4
4
4
4
7
5
9
4
4
4
4
31
7
Interest
2
3
4
7
5
6
6
7
6
8
8
12
15
Depreciation
16
18
21
18
21
22
23
22
22
23
23
22
28
PBT
19
14
17
22
24
28
28
29
26
31
21
54
22
Tax %
18%
20%
20%
17%
23%
23%
24%
28%
26%
24%
22%
20%
26%
Net Profit
15
11
14
18
18
22
22
21
20
23
16
43
16
EPS (₹)
4.86
3.6
4.21
5.7
5.63
6.8
6.69
6.53
6.03
7.16
5.08
13.37
4.88
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
36
57
108
147
258
396
455
464
590
682
691
726
Expenses
35
42
169
87
373
302
320
340
444
485
478
507
Operating Profit
0
15
-62
60
-114
94
135
124
146
197
213
219
OPM %
0.6%
26%
-57%
41%
-44%
24%
30%
27%
25%
29%
31%
30%
Other Income
3
4
3
2
13
265
15
19
17
26
43
47
Interest
6
6
8
16
25
26
18
8
16
25
34
42
Depreciation
5
10
18
26
32
37
41
54
75
88
90
96
PBT
-7
2
-84
21
-158
295
90
82
72
110
132
128
Tax %
6%
8%
-29%
40%
-29%
37%
21%
23%
19%
24%
22%
—
Net Profit
-8
2
-60
12
-112
185
71
64
59
83
103
99
EPS (₹)
-15.05
4.01
-117
24.15
-217
285
22.52
20.23
18.14
25.65
31.65
30.49
Div. Payout %
0%
0%
0%
0%
0%
0%
11%
14%
14%
11%
6%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
5
5
—
5
5
6
16
16
16
16
16
Reserves
4
6
—
43
-217
-17
671
727
799
877
976
Borrowings
131
102
—
330
246
474
41
32
160
202
531
Other Liabilities
24
63
—
115
596
146
149
134
197
188
295
Total Liabilities
163
176
—
493
630
609
877
909
1,172
1,283
1,818
Fixed Assets
59
116
—
223
275
309
386
471
647
668
651
CWIP
20
6
—
42
9
4
28
25
10
3
208
Investments
0
0
—
0
0
0
0
0
0
32
58
Other Assets
85
53
—
228
345
297
463
413
514
581
902
Total Assets
163
176
—
493
630
609
877
909
1,172
1,283
1,818
Figures in ₹ Crores

Cash Flow

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
59
—
61
38
119
129
75
24
89
134
Investing
—
-53
—
-201
-77
-67
-241
-109
-129
-102
-391
Financing
—
-37
—
145
6
20
176
-33
84
14
278
Net Cash Flow
—
-31
—
4
-33
71
64
-66
-20
1
22
Free Cash Flow
—
6
—
-42
-39
50
-2
-59
-169
-21
-80
CFO/OP
—
410
—
114
-42
134
100
71
30
55
75
Figures in ₹ Crores

Ratios

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
87
91
—
140
87
69
48
59
110
152
163
Inventory Days
21
24
—
89
—
—
—
—
—
—
—
Days Payable
76
99
—
878
—
—
—
—
—
—
—
Cash Conversion Cycle
32
15
—
-650
87
69
48
59
110
152
163
Working Capital Days
-428
-119
—
-234
-133
-82
-21
16
-18
28
66
ROCE %
—
7%
—
—
-65%
129%
18%
12%
10%
13%
13%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Krsnaa Diagnostics insights

60 extracted metrics + investor summaries across FY16–FY27.

Shareholding Pattern

Public28.57%Promot.27.11%FIIs3.84%DIIs14.50%Others25.97%As ofSep 2026

Documents

Frequently Asked Questions about Krsnaa Diagnostics

What does Krsnaa Diagnostics Ltd do?
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]
Where is Krsnaa Diagnostics Ltd (KRSNAA) listed?
Krsnaa Diagnostics Ltd trades as KRSNAA on the NSE and under code 543328 on the BSE.
Which sector does Krsnaa Diagnostics Ltd belong to?
Krsnaa Diagnostics Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Krsnaa Diagnostics Ltd?
Krsnaa Diagnostics Ltd has a market capitalisation of ₹1,610 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Krsnaa Diagnostics Ltd?
Krsnaa Diagnostics Ltd trades at a PE ratio of 16.28 as of 28 Oct 2026, on earnings per share of ₹30.49, against a book value of ₹302.23 per share.
What is the 52-week high and low of Krsnaa Diagnostics Ltd?
Over the last 52 weeks Krsnaa Diagnostics Ltd has traded between ₹486 and ₹838 as of 28 Oct 2026.
Does Krsnaa Diagnostics Ltd pay dividends?
Krsnaa Diagnostics Ltd has a dividend yield of 0.40%.
What is the Return on Equity (ROE) of Krsnaa Diagnostics Ltd?
Krsnaa Diagnostics Ltd reported a return on equity of 10.35%. Its debt-to-equity ratio is 0.54.

Company Information

Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]

Website krsnaadiagnostics.com
Listed 2021-08-16
Face Value ₹ 5
Shares Outstanding 3,24,38,672

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/KRSNAA.md for Krsnaa Diagnostics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month